Clinical Trial

CMR-derived Quantitative Perfusion for Prediction of FFR

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients will undergo quantitative perfusion assessment in cardiovascular magnetic resonance imaging (dual bolus or dual sequence approach) as well as invasive coronary angiography for assessment of fractional flow reserve (FFR) including assessment of coronary flow reserve (CFR) and microcirculatory resistance (IMR).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Trial Details
NCT Number NCT07018778
Lead Sponsor Kerckhoff Klinik
Conditions Chronic Coronary Syndrome
Enrollment 200 participants
Start Date 2025-07-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-18